Bristol-Myers Squibb Company (BMY)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 11:53AM EDT. Market open.
| Previous Close | 48.86 |
| Open | 47.39 |
| Bid | 45.08 x 1000 |
| Ask | 45.09 x 800 |
| Day's Range | 44.67 - 47.50 |
| 52 Week Range | 44.67 - 69.10 |
| Volume | |
| Avg. Volume | 15,456,937 |
| Market Cap | 91.052B |
| Beta (5Y Monthly) | 0.39 |
| PE Ratio (TTM) | 11.64 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.40 (4.91%) |
| Ex-Dividend Date | Apr 04, 2024 |
| 1y Target Est | N/A |
- Barrons.com
Bristol Myers Cuts Full-Year Earnings Forecast, Launches Cost Cuts
The pharmaceutical company is implementing an initiative to cut costs by $1.5 billion by 2025 that will include about 2,200 job cuts.
- Investor's Business Daily
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat.
- Zacks
Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Bristol Myers (BMY) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
© 2024 Yahoo. All rights reserved.